PDGFRB and neoplasm: Notably, both tumor center and invasion front harbored higher α-SMA+ stromal fibroblasts in WPOI 4–5 compared to the WPOI 1–3 tumors, which was confirmed by fibronectin and PDGFRβ immunoreactivity (Supplementary Fig. 1l, m).